Nutex Health (NASDAQ:NUTX) Shares Down 5.9% - What's Next?

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) fell 5.9% during mid-day trading on Tuesday . The stock traded as low as $115.00 and last traded at $110.75. 53,381 shares traded hands during trading, a decline of 28% from the average session volume of 74,106 shares. The stock had previously closed at $117.66.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on NUTX. Benchmark lifted their price target on Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research note on Thursday, May 15th. Wall Street Zen downgraded Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Finally, Maxim Group lifted their price target on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th.

Nutex Health Trading Down 2.1%

The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The company has a 50 day simple moving average of $136.37 and a 200 day simple moving average of $77.01. The company has a market capitalization of $679.27 million, a PE ratio of -13.03 and a beta of 0.04.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $2.71. The business had revenue of $211.79 million during the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insider Activity

In other Nutex Health news, CFO Jon Christian Bates purchased 1,000 shares of the firm's stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average price of $81.81 per share, with a total value of $81,810.00. Following the purchase, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. This trade represents a 25.72% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 38.52% of the company's stock.

Hedge Funds Weigh In On Nutex Health

Several large investors have recently made changes to their positions in NUTX. Bank of America Corp DE lifted its stake in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after purchasing an additional 2,043 shares in the last quarter. Northern Trust Corp acquired a new stake in shares of Nutex Health during the fourth quarter worth about $200,000. Millennium Management LLC acquired a new position in shares of Nutex Health in the fourth quarter valued at approximately $213,000. World Investment Advisors purchased a new stake in Nutex Health during the 4th quarter worth approximately $217,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in Nutex Health in the 4th quarter valued at approximately $231,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.